Testimonials

Attendee Quotes from the 2024 Next Generation Dx Summit:

“What an amazing opportunity to connect with companies developing important technologies!”,
Chang Hee Kim, CEO, GoDx

“The most valuable conference for the commercialization of diagnostics with excellent opportunities for one-on-one networking with industry insiders.”
Evgueni Klinski, Principal Scientist, UCM Technologies Inc.

“Great speakers and an opportunity to network across different disciplines.”
Tanya M Gottlieb, VP Scientific Affairs, MeMed

“One of the best networking events in Diagnostics.”
Joen Johansen, President, MDC Associates, Inc.

“Learned upcoming test options for TB and STI.”
Santina Castriciano, Dir Global Scientific Affairs, Coapn

“I think the panel discussion on the FDA's Final Rule regulating LDTs featured speakers who were key stakeholders and was lively and informative.”
Glenn Harbold, Director, Solution Strategy, Quadax

“Discover the latest expert insights and trends in health innovation and cutting-edge technologies.”
Bernard Gouget, IFCC Committee Chair, IFCC- Intl Federation of Clinical Chemistry

“The conference excelled in networking opportunities and provided insights into key issues currently impacting the lab diagnostics sector. The downtown D.C. location facilitated the organization of networking events, benefiting from the city's walkability and vibrant atmosphere.”
Chad Miles, Director Reimbursement Management, Quadax Inc.

Attendee Quotes from the 2022 Next Generation Dx Summit:

“I have attended the Liquid Biopsy conferences several times and found them invaluable. All the biotech specialty companies are there to interact with as well as speakers. The speakers are excellent and top of the field. I have formed collaborations with 2 cutting edge companies that I met at these meetings that resulted in grants and papers. I highly recommend them.”
Lynn Pulliam, PhD, Professor, Departments of Laboratory Medicine and Medicine, University of California, San Francisco

“The Next Generation Dx Summit brings together experts in laboratory diagnostics to discuss advances in technology and how testing can be applied to care for patients. It’s an excellent forum to share best practices and learn about cutting edge technology that has the potential to transform healthcare.”
Matthew Binnicker, PhD, Consultant, Division of Clinical Microbiology; Vice Chair of Practice, Department of Laboratory Medicine and Pathology, Mayo Clinic

“Next Generation Dx Summit an excellent event to see find the latest development of various diagnostic platforms from both academia and industry and discuss how these new technologies could be translated into the clinic and make an impact on patient care.”
Hyungsoon Im, PhD, Assistant Professor, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School

"I enjoyed the last Next Generation Dx Summit in Washington DC. Excellent program with expert speakers focusing on Liquid biopsy and lots of time for discussion and creating new collaborations. This meeting has a great impact on the Liquid biopsy community."
Klaus Pantel, PhD, Professor, Medicine & Director & Chairman, Institute of Tumor Biology, University Hospital Hamburg, Eppendorf

“I enjoyed the NextGenDx meeting and presented my work successfully there. Nice coordination, venue and location!”
Andi Cani, PhD, Postdoc, Daniel F. Hayes Group, Division of Hematology and Oncology, Rogel Cancer Center; Department of Internal Medicine, Michigan Medicine, University of Michigan Medical School

“The Next Gen Dx summit always provides an excellent opportunity to further your knowledge, learn about emerging trends in the industry, share best practices and network.  We all have a handful of choices for industry meetings and conferences to attend every year.  I continue to find this conference extremely informative – and well worth the investment.” 
Timothy I. Still, Chief Executive Officer, Sense Biodetection Limited

“Next Generation Dx Summit was a great opportunity to learn and discuss the current state-of-the-art technologies researchers are developing and clinically testing. Moreover, it was a perfect forum to initiate new collaborations. After 3 years of virtual meetings during the pandemic, the Next Generation Dx Summit enabled us to meet old friends and make new ones, too.”
Lydia Sohn, PhD, Chancellor’s Professor, Mechanical Engineering, University of California, Berkeley

“Excellent meeting that offers interesting and innovative presentations and discussions from clinical experts and industry partners.”
Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Associate Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California

“NextGenDx Summit continues to impress. I appreciate the mix of science and commercial nature of the presentations as well as the incredible networking opportunities. For me, it hits that sweet spot of education and connection.”
Jordan S. Laser, MD, Chief Laboratory Officer, Everly Health

“Next Gen Dx gives me access to key opinion leaders and decision makers in and outside of the diagnostic industry. It keeps me abreast of the important trends coming and gives me the ability to build partnerships and expand my network.”
Kenneth C. Hohmeier, PharmD, Associate Professor, Director of Community Affairs, PGY-1 Community-Based Pharmacy Residency Program, The University of Tennessee Health Science Center

“The Next Generation Dx Summit is a great opportunity to network with colleagues involved with clinical laboratory diagnostics. This meeting is attended by laboratory directors and clinical laboratory scientists as well as industry research and development staff and provides the ability for interaction between the clinical lab and the industry.”
James Nichols, PhD, DABCC, FACB, Professor of Pathology, Microbiology and Immunology, Medical Director, Clinical Chemistry and POCT, Vanderbilt University School of Medicine

“I found the Next Generation Dx Summit a valuable conference for those engaged in pushing sequencing technology into the clinical diagnostic space. The NextGenDx Summit is the perfect conference for those pursuing cutting edge translational diagnostics.”
Benjamin Briggs, MD, PhD, CMO, CosmosID

“This was my first ever summit of this kind. It was an honor to share our team’s work to the attendees. Beyond that, I was enriched by both the conference content and the ability to network with attendees. This conference has enabled me to be both informed about the diagnostic trends in the USA while sharing our experience in Canada. For this reason, I would want to be a regular attendee going forward.”
AbdulRazaq A. H. Sokoro, PhD, FCACB, FAACC, Executive Director, Provincial Laboratory Operations, Diagnostic Services, Shared Health; Associate Head, Department of Pathology; Associate Professor, Departments of Internal Medicine and Pathology; Program Director, Clinical Biochemistry Post-Doctoral Training Program, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba

"The Next-Gen Diagnostics Summit showcased an important range of technologies and applications, especially in the Early Cancer Surveillance track.  It is critical that we, as early detection companies, hold one another accountable to unlocking disease detection at its earliest stages so that providers and patients have the diagnostics necessary to meaningfully improve outcomes."
Elizabeth Cormier-May, CEO, Mammogen, Inc.; CCO, IV BioHoldings, LLC

“I was struck by the diversity of the attendees that enabled well-rounded discussion on early detection in terms of technology, performance, regulatory as well as clinician and patient experience.”
Gulfem Guler, PhD, Director, Translational Research, Bluestar Genomics

“It was one of the most productive and informative conferences I have attended this year”
Christopher Hibberd, Executive Chairman & CEO, Nucleix